期刊文献+

长春花碱酰胺联合化疗治疗非霍奇金淋巴瘤35例临床观察

Clinical Observation on Vindensine- Based Combination Chemotherapy in Patients with Non- Hodgkin's Lymphoma
下载PDF
导出
摘要 目的:观察长春花碱酰胺(VDS)组成的联合方案治疗非霍奇金淋巴瘤(NHL)的疗效及毒副反应。方法:35例NHL用以下方案化疗:CTX500mg/m2,iv,第1、8天;ADM30~40mg/m2,iv,第1天;VDS2.5~3mgm2,iv,第1、8天;PDN100mg日,po,第1至5天,21~28天为1周期。全部病例用药均在2周期以上。结果:全组35例,CR9例,PR22例,总有效率88.6%。主要毒副反应有骨髓抑制、恶心、呕吐、脱发等。 This study is to investigeate the efficacy and toxicity of Vindesine-based combination chemotherapy of Non-Hodgkin 's lymphoma. Methods: 35 patients with Non-Hodgkin's lymphoma were given CTX anmg/m2 iv,on day l,8;Vindensine 2.5 ~ 3 mg/m2 iv,on day l,8;ADM 30 ~ 40 mg/m2 iv,on dayl;PDN 100mgpo,on day1 to day5.21 to 28 days was cycle.All patients finished above two cycles.Results:All 35 patientswere evaluable for response and toxicity.Response rate was 88.6% including 9 of complete response and 22 ofpartial response. Main toxicity were myelosuppression, nauaea, vomiting and alepcia.
出处 《河南肿瘤学杂志》 1998年第5期367-368,共2页 Henan Journal of Oncology
关键词 长春花碱酰胺 联合化疗 非霍奇金淋巴瘤 Vindesine, combination combination , Non-Hodgkin 's lymphoma
  • 相关文献

参考文献2

共引文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部